NCT03434613View on ClinicalTrials.gov

Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 14, 2018

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions

Nonalcoholic Fatty Liver DiseaseDyslipidemias

Interventions

DRUG

Rosuvastatin

Rosuvastatin 5mg 1T daily for 6 months

DRUG

Rosuvastatin/ezetimibe combination

Rosuvastatin 5mg / Ezetimibe 10mg combination 1T daily for 6 months

Trial Locations (1)

03722

Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT03434613 - Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter